AstraZeneca is staying on Facebook

As the Washington Post noted over the weekend, some biopharmaceutical companies are removing their corporate or branded Facebook pages in light of changes the social network made to its commenting policies.

We are keeping our Facebook page for the US business.

Why? Because our presence on Facebook – along with this blog and @AstraZenecaUS and @AZHelps on Twitter – helps us listen to and participate in important conversations about health care in the United States.

Given regulatory restrictions, however, we do face some challenges in fully engaging on Facebook or through other social media channels. Some of those challenges are laid out in our commenting policy, which details when and why we may delete some comments from our posts or wall.

So take a look and consider liking us on Facebook, and we look forward to continuing the conversation with you all.

8 comments